Bioventus Inc. (BVS): R&D Expense
$12.11M
Year ended 2025-12-31
$11.57M
Trailing 12 months to 2026-06-27
-20.2%
3-year compound annual growth
+1.6%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.11M | -13.2% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $13.95M | +3.8% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | $13.45M | -43.6% | 2026-03-05, From 2023-01-01 |
| 2022-12-31 | $23.85M | +25.3% | 2025-03-11, From 2022-01-01 |
| 2021-12-31 | $19.04M | +70.0% | 2024-03-12, From 2021-01-01 |
| 2020-12-31 | $11.20M | +1.3% | 2023-03-31, From 2020-01-01 |
| 2019-12-31 | $11.05M | n/a | 2022-03-11, From 2019-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Bioventus Inc. (BVS) | 2025-12-31 | $12.11M | -13.2% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $8.60M | -17.3% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $99.21M | +3.2% |
| Glaukos Corp (GKOS) | 2025-12-31 | $150.61M | +10.4% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $224.54M | +7.1% |
| Artivion, Inc. (AORT) | 2025-12-31 | $30.99M | +8.9% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $84.61M | +18.4% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $76.27M | -5.5% |
| Mimedx Group, Inc. (MDXG) | 2025-12-31 | $15.10M | +22.3% |
Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗